Ghent University, Department of Developmental, Personality and Social Psychology, H. Dunantlaan 2, B-9000 Ghent, Belgium.
J Pers Disord. 2011 Feb;25(1):1-15. doi: 10.1521/pedi.2011.25.1.1.
In literature, there exists disagreement regarding the impact of comorbid personality disorder(s) (PD[s]) on treatment outcome for patients with major depressive disorder (MDD). The aim of this paper was to investigate whether statistical heterogeneity and inter-dependency are potential moderators of the effect of co-morbid PDs on outcome for patients with MDD. Clinician-rated MADRS scores and DSM-IV Axis II personality disorder diagnoses were obtained from 562 outpatients with MDD who received 6 months of combined psycho- and pharmacotherapy. Single-level regression showed significantly worse treatment outcome among patients with co-morbid PD, as compared to patients with no PD. After controlling for statistical heterogeneity and interdependency, treatment outcome was no longer significantly worse for patients with co-morbid PD. In conclusion, heteroscedasticity and inter-dependency should be considered as potentially compelling explanations for inconsistencies in findings on treatment outcome for depressed patients with co-morbid PDs.
在文献中,对于共患人格障碍(PD)对重度抑郁症(MDD)患者治疗结果的影响存在分歧。本文的目的是研究共患 PD 是否对 MDD 患者的治疗结果存在统计学异质性和相互依存性的潜在调节作用。从 562 名接受 6 个月心理和药物联合治疗的 MDD 门诊患者中获得了临床医生评定的 MADRS 评分和 DSM-IV 轴 II 人格障碍诊断。单水平回归显示,与无 PD 的患者相比,共患 PD 的患者治疗结果明显更差。在控制了统计学异质性和相互依存性之后,共患 PD 患者的治疗结果不再显著更差。总之,异方差和相互依存性应该被认为是解释伴有共患 PD 的抑郁患者治疗结果不一致的潜在有力因素。